In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.

This content is currently on FREE ACCESS

Advancing standard of care in patients with HFrEF – what does it take?

Session Evolving clinical practice for optimized treatment of patients with heart failure with reduced ejection fraction (HFrEF)

Speaker Atul Pathak, Associate Professor Rolf Wachter, Maria Generosa Crespo-Leiro, Aldo Pietro Maggioni, Roy Stuart Gardner

Event : ESC Congress 2017

  • Topic : cardiovascular pharmacology
  • Sub-topic : Pharmacology and Pharmacotherapy
  • Session type : Satellite Symposium
  • Sponsored by Novartis Pharma AG

This content is currently on FREE ACCESS

Get your access to resources

Join now
  • 1ESC Professional Members – access all ESC Congress resources 
  • 2ESC Association Members (Ivory, Silver, Gold) – access your Association’s resources
  • 3Under 40 or in training - with a Combined Membership, access all resources
Join now

Our sponsors

ESC 365 is supported by Bayer, Boehringer Ingelheim and Lilly Alliance, Bristol-Myers Squibb and Pfizer Alliance, Novartis Pharma AG and Vifor Pharma in the form of educational grants. The sponsors were not involved in the development of this platform and had no influence on its content.

logo esc

Our mission: To reduce the burden of cardiovascular disease

Who we are